ARTICLES Cell Research (2004); 14(6):473-479 Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA Chang You LI1, Jia You CHU1,*, Jian Kun YU1, Xiao Qin HUANG1, Xiao Juan LIU1, Li SHI1, Yan Chun CHE1, Jiu Yong XIE2,* 1Institute of Medical Biology, Chinese
Academy of Medical Sciences and Peking Union Medical College, Kunming
650118, China. Received, Feb 18, 2004 Revised, Sep 24, 2004 Accepted, Oct 5, 2004
The splicing of many alternative exons in the precursor messenger RNA (pre-mRNA) is regulated by extracellular factors but the underlying molecular bases remain unclear. Here we report the differential regulation of Bcl-x pre-mRNA splicing by extracellular factors and their distinct requirements for pre-mRNA elements. In K562 leukemia cells, treatment with interleukin-6 (IL-6) or granulocyte-macrophage colony stimulating factor (GM-CSF) reduced the proportion of the Bcl-xL variant mRNA while treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) had no effect. In U251 glioma cells, however, TPA efficiently increased the Bcl-xL level. These regulations were also seen for a transfected splicing reporter mini-gene. Further analyses of deletion mutants indicate that nucleotides 1-176 of the downstream intron are required for the IL-6 effect, whereas additional nucleotides 177-284 are essential for the GM-CSF effect. As for the TPA effect, only nucleotides 1-76 are required in the downstream intron. Thus, IL-6, GM-CSF and TPA differentially regulate Bcl-x splicing and require specific intronic pre-mRNA sequences for their respective effects. Keywords: alternative splicing, bcl-x gene, cytokine, TPA, pre-mRNA element. |
copyright©2006 Institute of Biochemistry and Cell Biology,SIBS,CAS
ISSN:1001-0602(Print),1748-7838(Online);CN:31-1568
suggested resolution 1024*768